A randomized, open-label, pilot clinical study to evaluate the effect of omega-3-enriched egg supplementation in healthy participants
Abstract
BackgroundOmega-3 fatty acids are beneficial for health. Omega-3-enriched eggs provide an alternative to enhance dietary omega-3 intake.ObjectiveTo evaluate the change in EPA (eicosapentaenoic acid), DHA (docosahexaenoic acid) and total omega-3 fatty acids levels in blood after consuming omega-3-enriched eggs in healthy participants and compare with regular eggs and fish oil capsules.MethodsA randomized, open-label, pilot clinical study allocated 43 participants into four groups as follows: Group 1 (n = 10): One omega-3-enriched egg daily, Group 2 (n = 10): Two omega-3-enriched eggs daily, Group 3 (n = 12): One fish oil capsule once daily containing 250 mg EPA + DHA, Group 4 (n = 11): One regular (control) egg daily for 30 days. The primary outcome was the change in EPA, DHA, and total omega-3 fatty acid levels in blood plasma on Day 15 and Day 30 compared to baseline.ResultsConsuming one omega-3-enriched egg daily for 30 days increased DHA levels by 63.66%. While fish oil capsules increased plasma DHA level by 91.48%. The highest increase in DHA was in the two omega-3 egg group (92.52%). EPA levels significantly increased (117.46%) in participants consuming two omega-3-enriched eggs daily, which was significantly higher than the fish oil capsule group (111.08%). Total plasma omega-3 levels increased by 97.41% in the two-enriched-egg group, compared to 13.37% in the regular egg group.ConclusionOmega-3-enriched eggs can be an ideal alternative for individuals who consume eggs…
How strong is the evidence?
Evidence Hub reads this as a randomized trial, done in people. Its evidence level is 2 of 5 (High · randomized trial). Randomized trials of a reasonable size are the strongest single-study design. Reported size: 43 participants or records.
Read the paper
Related studies
- eggNOG 5.0: a hierarchical, functionally and phylogenetically annotated orthology resource based on 5090 organisms and 2502 viruses
- Online Survival Analysis Software to Assess the Prognostic Value of Biomarkers Using Transcriptomic Data in Non-Small-Cell Lung Cancer
- OptiType: precision HLA typing from next-generation sequencing data
- Nicotinic Cholinergic System and COVID-19: In Silico Identification of an Interaction between SARS-CoV-2 and Nicotinic Receptors with Potential Therapeutic Targeting Implications
- Saccharomyces cerevisiae cells have three Omega class glutathione S-transferases acting as 1-Cys thiol transferases
- Hemolysis at low blood flow rates: in-vitro and in-silico evaluation of a centrifugal blood pump
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.